Evidence map›Paper›PMID 35096404›Full record

ArticleNeuro-oncology practice2022

Classical and disease-specific quality indicators in glioma surgery-Development of a quality checklist to improve treatment quality in glioma patients.

Christiane Menke, Sebastian Lohmann, Andrea Baehr, Oliver Grauer, Markus Holling, Benjamin Brokinkel, Michael Schwake, Walter Stummer, Stephanie Schipmann

Abstract read
In one paragraph

Article in Neuro-oncology practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Christiane MenkeDepartment of Neurosurgery, University Hospital Münster, Münster, Germany.
Sebastian LohmannDepartment of Neurosurgery, University Hospital Münster, Münster, Germany.
Andrea BaehrDepartment of Radiation Oncology, University Hospital Münster, Münster, Germany.
Oliver GrauerDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
Markus HollingDepartment of Neurosurgery, University Hospital Münster, Münster, Germany.
Benjamin BrokinkelDepartment of Neurosurgery, University Hospital Münster, Münster, Germany.
Michael SchwakeDepartment of Neurosurgery, University Hospital Münster, Münster, Germany.
Walter StummerDepartment of Neurosurgery, University Hospital Münster, Münster, Germany.ORCID https://orcid.org/0000-0002-3460-0640
Stephanie SchipmannDepartment of Neurosurgery, University Hospital Münster, Münster, Germany.ORCID https://orcid.org/0000-0002-9971-2256

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is a pressing demand for more accurate, disease-specific quality measures in the field of neurosurgery. Aiming at most adequately measuring and reflecting the quality of glioma therapy, we developed a novel quality indicator bundle in form of a checklist for all patients that are treated operatively for glioma.

methodsOn the basis of possible glioma-specific quality indicators retrieved from the literature and quality guidelines, a multidisciplinary team developed a checklist containing 13 patient-need-specific outcome measures. Subsequently, the checklist was prospectively applied to a total of 78 patients compared with a control group consisting of 322 patients. A score was generated based on the maximum of quality measures achieved.

resultsSignificant improvements in quality after prospectively introducing the checklist were achieved for supplemental physical and occupational therapy during inpatient stay (89.4% vs 100%,

conclusionsAiming at ensuring comprehensive, consistent, and timely care of glioma patients, the implementation of the checklist for routine use in glioma surgery represents an efficient, easily reproducible, and powerful tool for significant improvements.

Indexed as

glioblastomagliomaquality indicatorsreadmissionreoperation

Identifiers

PMID35096404
PMCPMC8789264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.